Curis Inc (CRIS)
16.36
-0.15
(-0.91%)
USD |
NASDAQ |
May 03, 16:00
16.70
+0.34
(+2.08%)
After-Hours: 20:00
Curis Revenue (Quarterly): 2.696M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.696M |
| September 30, 2023 | 2.833M |
| June 30, 2023 | 2.197M |
| March 31, 2023 | 2.297M |
| December 31, 2022 | 2.887M |
| September 30, 2022 | 2.825M |
| June 30, 2022 | 2.393M |
| March 31, 2022 | 2.057M |
| December 31, 2021 | 3.135M |
| September 30, 2021 | 3.039M |
| June 30, 2021 | 2.286M |
| March 31, 2021 | 2.189M |
| December 31, 2020 | 3.024M |
| September 30, 2020 | 2.742M |
| June 30, 2020 | 2.36M |
| March 31, 2020 | 2.709M |
| December 31, 2019 | 3.287M |
| September 30, 2019 | 2.856M |
| June 30, 2019 | 2.094M |
| March 31, 2019 | 1.767M |
| December 31, 2018 | 2.755M |
| September 30, 2018 | 2.847M |
| June 30, 2018 | 2.358M |
| March 31, 2018 | 2.468M |
| December 31, 2017 | 3.262M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.444M |
| June 30, 2017 | 2.061M |
| March 31, 2017 | 2.131M |
| December 31, 2016 | 2.362M |
| September 30, 2016 | 1.759M |
| June 30, 2016 | 1.68M |
| March 31, 2016 | 1.726M |
| December 31, 2015 | 2.092M |
| September 30, 2015 | 2.045M |
| June 30, 2015 | 2.083M |
| March 31, 2015 | 1.658M |
| December 31, 2014 | 1.992M |
| September 30, 2014 | 1.765M |
| June 30, 2014 | 4.801M |
| March 31, 2014 | 1.285M |
| December 31, 2013 | 1.524M |
| September 30, 2013 | 7.202M |
| June 30, 2013 | 5.404M |
| March 31, 2013 | 0.8714M |
| December 31, 2012 | 1.686M |
| September 30, 2012 | 0.5778M |
| June 30, 2012 | 4.352M |
| March 31, 2012 | 10.36M |
| December 31, 2011 | 14.09M |
| September 30, 2011 | 0.1471M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.057M
Minimum
Mar 2022
3.287M
Maximum
Dec 2019
2.627M
Average
2.709M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 0.065M |
| Perspective Therapeutics Inc | -5.239M |
| Protalix BioTherapeutics Inc | 10.49M |
| Electromed Inc | 13.69M |
| Armata Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.71M |
| Total Expenses (Quarterly) | 14.90M |
| EPS Diluted (Quarterly) | -2.03 |
| Enterprise Value | 40.09M |
| Gross Profit Margin (Quarterly) | 98.00% |
| Profit Margin (Quarterly) | -434.4% |
| Earnings Yield | -54.77% |
| Normalized Earnings Yield | -54.77 |